Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Harold Bays

Showing results (1-10 of 77) with videos related to

Pageof 8
Sort By:
Drugs in R&D|August 23, 2006
The melanocortin system as a therapeutic treatment target for adiposity and adiposopathyHarold Bays
The American Journal of Cardiology|May 12, 2007
Fish oil composition of Omacor and the GISSI trialHarold Bays
The American Journal of Cardiology|August 22, 2006
Clinical overview of Omacor: a concentrated formulation of omega-3 polyunsaturated fatty acidsHarold Bays
Current Medical Research and Opinion|February 24, 2009
From victim to ally: the kidney as an emerging target for the treatment of diabetes mellitusHarold Bays
Expert Review of Cardiovascular Therapy|August 17, 2010
Phentermine, topiramate and their combination for the treatment of adiposopathy ('sick fat') and metabolic diseaseHarold Bays
Drugs of Today (Barcelona, Spain : 1998)|June 10, 2008
Rationale for prescription omega-3-acid ethyl ester therapy for hypertriglyceridemia: a primer for cliniciansHarold Bays
Expert Review of Cardiovascular Therapy|April 28, 2005
Adiposopathy: role of adipocyte factors in a new paradigmHarold Bays
Expert Review of Cardiovascular Therapy|May 14, 2005
Adiposopathy, metabolic syndrome, quantum physics, general relativity, chaos and the Theory of EverythingHarold Bays
The American Journal of Cardiology|April 4, 2006
Statin safety: an overview and assessment of the data--2005Harold Bays
Postgraduate Medicine|April 1, 2009
Review of ARBITER 2: extended-release niacin added to statin therapy slows the progression of atherosclerosis. CommentaryHarold Bays
Pageof 8

Showing results (1-10 of 77) with videos related to

Sort By:
Pageof 8
Drugs in R&D|August 23, 2006
The melanocortin system as a therapeutic treatment target for adiposity and adiposopathyHarold Bays
The American Journal of Cardiology|May 12, 2007
Fish oil composition of Omacor and the GISSI trialHarold Bays
The American Journal of Cardiology|August 22, 2006
Clinical overview of Omacor: a concentrated formulation of omega-3 polyunsaturated fatty acidsHarold Bays
Current Medical Research and Opinion|February 24, 2009
From victim to ally: the kidney as an emerging target for the treatment of diabetes mellitusHarold Bays
Expert Review of Cardiovascular Therapy|August 17, 2010
Phentermine, topiramate and their combination for the treatment of adiposopathy ('sick fat') and metabolic diseaseHarold Bays
Drugs of Today (Barcelona, Spain : 1998)|June 10, 2008
Rationale for prescription omega-3-acid ethyl ester therapy for hypertriglyceridemia: a primer for cliniciansHarold Bays
Expert Review of Cardiovascular Therapy|April 28, 2005
Adiposopathy: role of adipocyte factors in a new paradigmHarold Bays
Expert Review of Cardiovascular Therapy|May 14, 2005
Adiposopathy, metabolic syndrome, quantum physics, general relativity, chaos and the Theory of EverythingHarold Bays
The American Journal of Cardiology|April 4, 2006
Statin safety: an overview and assessment of the data--2005Harold Bays
Postgraduate Medicine|April 1, 2009
Review of ARBITER 2: extended-release niacin added to statin therapy slows the progression of atherosclerosis. CommentaryHarold Bays
Pageof 8